GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ashland Inc (NYSE:ASH) » Definitions » Change In Payables And Accrued Expense

Ashland (Ashland) Change In Payables And Accrued Expense

: $0 Mil (TTM As of Dec. 2023)
View and export this data going back to 1950. Start your Free Trial

Ashland's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0 Mil. It means Ashland's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Ashland's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2023 was $-112 Mil. It means Ashland's Accounts Payable & Accrued Expense declined by $112 Mil from Sep. 2022 to Sep. 2023 .


Ashland Change In Payables And Accrued Expense Historical Data

The historical data trend for Ashland's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ashland Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Change In Payables And Accrued Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.00 -46.00 3.00 34.00 -112.00

Ashland Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ashland Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ashland Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ashland's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ashland (Ashland) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ashland Inc (NYSE:ASH) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
Address
8145 Blazer Drive, Wilmington, DE, USA, 19808
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.
Executives
Eric N Boni officer: Principal Accounting Officer 8145 BLAZER DRIVE, WILMINGTON DE 19808
J Kevin Willis officer: Chief Financial Officer 50 E RIVERCENTER BLVD, COVINGTON KY 41011
James P. Minicucci officer: SVP Strategy, M&A & Portfolio 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Karl R. Bostaph officer: SVP Operations 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Robin E. Lampkin officer: SVP, Gen. Counsel & Secretary 5475 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Sergio Pedreiro director 2 PARK AVENUE, NEW YORK NY 10016
Eileen Drury officer: SVP and Chief Human Resources 8145 BLAZER DRIVE, WILMINGTON DE 19808
Ricky C Sandler director, other: See Remarks 65 EAST 55TH STREET, 25TH FLOOR, NEW YORK NY 10022
Steven D Bishop director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Suzan F. Harrison director 77 WEST WACKER DRIVE, SUITE 4600, CHICAGO IL 60601
Guillermo Novo director, officer: Chairman and CEO AIR PRODUCTS AND CHEMICALS, INC., 7201 HAMILTON BOULEVARD, ALLENTOWN PA 18195
Winkler Von Mohrenfels Petra Yvonne officer: Sr. VP, GC and Secretary 8145 BLAZER DRIVE, WILMINGTON DE 19808
Min Chong officer: Sr VP & Gen Mgr, Spc Additives 8145 BLAZER DRIVE, WILMINGTON DE 19808
Osama M Musa officer: Sr. Vice President ASHLAND GLOBAL HOLDINGS INC, 1005 ROUTE 202/206, BRIDGEWATER NJ 08807
Swaminathan Ashok Kalyana officer: Sr VP & Gen Mgr, Life Sciences 8145 BLAZER DRIVE, WILMINGTON DE 19808